Temozolomide Salvage Chemotherapy for Recurrent Anaplastic Oligodendroglioma and Oligo-Astrocytoma
Ho-Shin Gwak, Gi Taek Yee, Chul-Kee Park, Jin Wook Kim, Yong-Kil Hong, Seok-Gu Kang, Jeong Hoon Kim, Ho Jun Seol, Tae-Young Jung, Jong Hee Chang, Heon Yoo, Jeong-Hyun Hwang, Se-Hyuk Kim, Bong Jin Park, Sun-Chul Hwang, Min Su Kim, Seon-Hwan Kim, Eun-Young Kim, Ealmaan Kim, Hae Yu Kim, Young-Cho Ko, Hwan Jung Yun, Ji Hye Youn, Juyoung Kim, Byeongil Lee, Seung Hoon Lee
J Korean Neurosurg Soc. 2013;54(6):489-495.   Published online 2013 Dec 31     DOI: https://doi.org/10.3340/jkns.2013.54.6.489
Citations to this article as recorded by Crossref logo
Current and Future Frontiers of Molecularly Defined Oligodendrogliomas
Jordina Rincon-Torroella, Maureen Rakovec, Josh Materi, Divyaansh Raj, Tito Vivas-Buitrago, Abel Ferres, William Reyes Serpa, Kristin J. Redmond, Matthias Holdhoff, Chetan Bettegowda, José Juan González Sánchez
Frontiers in Oncology.2022;[Epub]     CrossRef
Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas
Shalini Sundramurthi Chelliah, Ervin Ashley Lourdes Paul, Muhamad Noor Alfarizal Kamarudin, Ishwar Parhar
Molecules.2021; 26(4): 1169.     CrossRef
Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme
Shuhua Zheng, Wensi Tao
Cancers.2021; 13(5): 1013.     CrossRef
Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme
Shuhua Zheng, Wensi Tao
Cancers.2020; 12(9): 2368.     CrossRef
The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade III Cerebral Gliomas in Adults: Version 2019.01
Young Zoon Kim, Chae-Yong Kim, Jaejoon Lim, Kyoung Su Sung, Jihae Lee, Hyuk-Jin Oh, Seok-Gu Kang, Shin-Hyuk Kang, Doo-Sik Kong, Sung Hwan Kim, Se-Hyuk Kim, Se Hoon Kim, Yu Jung Kim, Eui Hyun Kim, In Ah Kim, Ho Sung Kim, Tae Hoon Roh, Jae-Sung Park, Hyun J
Brain Tumor Research and Treatment.2019; 7(2): 63.     CrossRef
The Korean Society for Neuro-Oncology (KSNO) Guideline for WHO Grade II Cerebral Gliomas in Adults: Version 2019.01
Young Zoon Kim, Chae-Yong Kim, Chan Woo Wee, Tae Hoon Roh, Je Beom Hong, Hyuk-Jin Oh, Seok-Gu Kang, Shin-Hyuk Kang, Doo-Sik Kong, Sung Hwan Kim, Se-Hyuk Kim, Se Hoon Kim, Yu Jung Kim, Eui Hyun Kim, In Ah Kim, Ho Sung Kim, Jae-Sung Park, Hyun Jin Park, San
Brain Tumor Research and Treatment.2019; 7(2): 74.     CrossRef
Regression of Recurrent High-Grade Glioma with Temozolomide, Dexamethasone, and Levetiracetam: Case Report and Review of the Literature
Ajaya Kumar A, Abu Abraham Koshy
World Neurosurgery.2017; 108: 990.e11.     CrossRef
Rechallenge temozolomide in glioma: A case series from India
VM Patil, R Tonse, R Kothari, A Chandrasekaran, N Pande, S Epari, T Gupta, R Jalali
Indian Journal of Cancer.2017; 54(1): 368.     CrossRef
A rare case of oligoastrocytoma with atypical symptoms initially diagnosed as multiple sclerosis: A case report
JIGUO GAO, YANLI TI, HONGMEI MENG, TENG ZHAO, CHUNKUI ZHOU, LIJUN ZHU, SHAOKUAN FANG
Molecular and Clinical Oncology.2016; 4(2): 206.     CrossRef
Temozolomide
Reactions Weekly.2015; 1548(1): 255.     CrossRef
Oligodendroglial Tumors
Kurt A. Jaeckle
Seminars in Oncology.2014; 41(4): 468.     CrossRef